louisiana glp-1 gi obstruction class action Lawsuit Against Ozempic Manufacturers Claims Gastroparesis Side Effects Were Not Adequately Disclosed on Drug Label louisiana glp-1 gastrointestinal obstruction class
Description
Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes

GLP-1 medications have transformed weight loss treatment by regulating hunger signals in your brain

According to the Cleveland Clinic, these medications help limit blood sugar by binding to GLP receptors to trigger...

Understanding the difference between appetite-suppressing drug classes helps patients and providers choose the most appropriate treatment based on individual physiology, comorbidities, and clinical response patterns
Supports GLP-1 Activity Metabolic Balance Appetite Control